Insulin sensitivity peaks in the morning, and the GIP receptor activation from retatrutide may synergize with this natural morning peak to produce slightly better glucose handling
None of those steps will be complete before late 2027 at the earliest
1 The standards for diabetes management from the American Diabetes Association (ADA) have evolved significantly in recent years, and their 2025 standards recommend SGLT2 inhibitors and GLP1 RAs as first-line, glucose-lowering medications for all patients with diabetes
[DOI] [PMC free article] [PubMed] [Google Scholar] 199.Dantas Machado A.C., Brown S.D., Lingaraju A., Sivaganesh V., Martino C., Chaix A., Zhao P., Pinto A.F.M., Chang M.W., Richter R.A., et al
A number of studies has suggested that IR might be the main mechanism of NAFLD (185, 186)